Literature DB >> 8723478

Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.

W C Ko1, K W Yu, C Y Liu, C T Huang, H S Leu, Y C Chuang.   

Abstract

A total of 234 clinical isolates of Aeromonas, primarily A. hydrophila, were collected for the present study. Most were isolates from blood. By the agar dilution method, more than 90% of the Aeromonas strains were found to be susceptible to moxalactam, ceftazidime, cefepime, aztreonam, imipenem, amikacin, and fluoroquinolones, but they were more resistant to tetracycline, trimethoprim-sulfamethoxazole, some extended-spectrum cephalosporins, and aminoglycosides than strains from the United States and Australia.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8723478      PMCID： PMC163303          DOI： 10.1128/AAC.40.5.1260

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Identification of Aeromonas strains to the genospecies level in the clinical laboratory.

Authors:  S L Abbott; W K Cheung; S Kroske-Bystrom; T Malekzadeh; J M Janda
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Aeromonas hydrophila: myofascial necrosis and sepsis.

Authors:  R B Vukmir
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

Authors:  J M Koehler; L R Ashdown
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity.

Authors:  T R Walsh; D J Payne; A P MacGowan; P M Bennett
Journal:  J Antimicrob Chemother       Date:  1995-02       Impact factor: 5.790

6.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Plasmids and resistance to antimicrobial agents in Aeromonas sobria and Aeromonas hydrophila clinical isolates.

Authors:  B J Chang; S M Bolton
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

8.  Importance of Aeromonas sobria in Aeromonas bacteremia.

Authors:  J M Janda; R Brenden
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

9.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Aeromonas bacteremia: review of 59 episodes.

Authors:  W C Ko; Y C Chuang
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079
View more
  23 in total

1.  Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents.

Authors:  Max Aravena-Román; Timothy J J Inglis; Barbara Henderson; Thomas V Riley; Barbara J Chang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe.

Authors:  Patrick Hochedez; Emilie Hope-Rapp; Claude Olive; Muriel Nicolas; Gilles Beaucaire; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

4.  Aeromonas and Pseudomonas: antibiotic and heavy metal resistance species from Iskenderun Bay, Turkey (northeast Mediterranean Sea).

Authors:  Fatih Matyar; Tamer Akkan; Yasemin Uçak; Buse Eraslan
Journal:  Environ Monit Assess       Date:  2009-06-24       Impact factor: 2.513

5.  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

6.  Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp.

Authors:  M Goñi-Urriza; M Capdepuy; C Arpin; N Raymond; P Caumette; C Quentin
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

7.  Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.

Authors:  Joshua R Shak; Jennifer A Whitaker; Bruce S Ribner; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

8.  Global protein expression profile response of planktonic Aeromonas hydrophila exposed to chlortetracycline.

Authors:  Wanxin Li; Zujie Yao; Xiangyu Zhang; Fang Huang; Wenxiong Lin; Xiangmin Lin
Journal:  World J Microbiol Biotechnol       Date:  2017-03-07       Impact factor: 3.312

9.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy.

Authors:  W C Ko; H M Wu; T C Chang; J J Yan; J J Wu
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.